Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Cooper Sponsors Bill to Repeal Law Blamed for Restricting DEA Opioid Enforcement


 

WASHINGTON, Oct. 19, 2017 - U.S. Rep. Jim Cooper (TN-05), joined by U.S. Rep. Evan Jenkins (WV-03), U.S. Rep. Ann McLane Kuster (NH-02) and U.S. Rep. Tim Ryan (OH-13), today introduced bipartisan legislation repealing the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

The Washington Post and "60 Minutes" recently revealed that the Act has severely restricted the ability of the Drug Enforcement Administration (DEA) to investigate and discipline opioid distributors suspected of illegal behavior. "It is clear that the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 has significantly and adversely affected the federal government's ability to crack down on opioid distributors that are endangering communities across the country," Ryan said.

"We need to restore DEA's full powers, not hamper the agency the way the drug industry wanted," Cooper said. "Congress made a terrible mistake letting the drug industry bill slip through. Congress should correct that mistake now!"

The 2016 Act altered DEA procedures and made it more difficult for the agency to combat the spread of opioids into the black market. "We need a DEA that is fully empowered to enforce opioid regulations and crack down on irresponsible distributors," Jenkins said.

"At a time when the opioid epidemic is impacting communities across the country, it's critical that no tools are taken off the table," Kuster noted. "We know that the opioid crisis has in part been fueled by the over prescribing of opioid pain medications and any limitations on the DEA's ability to get unneeded prescription drugs off the street must be eliminated. I'm pleased that we've been able to come together in a bipartisan fashion to introduce this bill to repeal provisions of the Ensuring Patient Access and Effective Drug Enforcement Act, which DEA officials cite as restricting their ability to do their job."

The House bill introduced today would restore the stronger, original standard. U.S. Sen. Claire McCaskill of Missouri has introduced companion legislation in the Senate.

"It appears that this law has significantly affected the government's ability to crack down on opioid distributors that are failing to meet their obligations and endangering our communities," McCaskill said. "That's why I introduced legislation that repeals this law and will continue my work investigating the role pharmaceutical distributors played in fueling this public health crisis."

 
Share:

Related Articles:


Recent Articles

THA, TMA, TNA Outline Legislative Priorities

With the Tennessee General Assembly back in full swing, the state's major healthcare associations outline 2020 priorities.

Read More

Cardiac Innovation in Nashville

From transplants to trials, Nashville hospitals are leading the way in cardiac care.

Read More

A Modern Love Story: Where Technology, Healthcare & Construction Go Hand-in-Hand

Technology has changed every aspect of our lives. In fact, I had a healthy laugh a few weeks ago when I showed my children an old rotary phone and, get this, they did not know what it was.

Read More

Reeves/Smith Bill to Prevent Next Generation of Nicotine Addiction Garners Broad Industry Support

In late January, a group of more than 25 organizations from across Tennessee announced their support for legislation that seeks to prevent the next generation of nicotine addicts in the state.

Read More

Physician Spotlight: A Heart for Healing

TriStar Summit cardiologist Kristen Kerr is passionate about education, improving outcomes in women's heart health.

Read More

Heart Monitor

Read More

Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

Read More

Endocrine Society Celebrates Progress from Bench to Bedside

Endocrine Society Chief Professional & Clinical Affairs Officer Robert Lash, MD, discusses the field, annual meeting, road shows and more.

Read More

NMGMA: 10 Minute Takeaway

During the January NMGMA meeting, representatives from Fox Fuel and Lovell Communications shared insights on effective communications.

Read More

Bringing Eye Health into Focus in 2020

A recent survey reveals most Americans have key gaps in knowledge of eye health.

Read More

Email Print
 
 

 

 


Tags:
DEA, Drug Enforcement Agency, Ensuring Patient Access and Effective Drug Enforcement Act of 2016, Jim Cooper, Opioid, Opioid Addiction, Opioid Epidemic
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: